Patent ID: 11938195
Assignee: BP INNOMED LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G | IPC A

Claim 8:
9. The polypeptide of claim 1, wherein the polypeptide comprises the structure: L1-A-L2-B-L3-C, wherein A is SEQ ID NO:2: B is SEQ ID NO:3; and C is SEQ ID NO:1; A is SEQ ID NO:3; B is SEQ ID NO:2; and C is SEQ ID NO:1; L1 is a linker having the formula: NH2(CF2)m(C═O)—, wherein m is a whole number selected from 2-8; and each of L2 and L3 is independently a polypeptide linker consisting of 1-3 glycine residues.